Neurokinin-1-tachykinin receptor agonist promotes diabetic fracture healing in rats with type 1 diabetes via modulation of Wnt/β-catenin signalling axis

Saudi Journal of Biological Sciences ◽

10.1016/j.sjbs.2021.02.026 ◽

2021 ◽

Author(s):

Xiaohui Wang ◽

Ning Su

Keyword(s):

Type 1 Diabetes ◽

Fracture Healing ◽

Receptor Agonist ◽

Tachykinin Receptor ◽

Download Full-text

148-LB: Efficacy and Safety of Adding an Oral Hypoglycemic Agent or a GLP-1 Receptor Agonist to Insulin in Patients with Type 1 Diabetes: A Network Meta-analysis

Diabetes ◽

10.2337/db19-148-lb ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 148-LB

Author(s):

YOON JI KIM ◽

SEUN DEUK HWANG ◽

SOO LIM

Keyword(s):

Type 1 Diabetes ◽

Receptor Agonist ◽

Meta Analysis ◽

Oral Hypoglycemic Agent ◽

Efficacy And Safety ◽

Hypoglycemic Agent

Download Full-text

Faculty Opinions recommendation of Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8727957.11798054 ◽

2011 ◽

Author(s):

Kyong Soo Park ◽

Soo Heon Kwak

Keyword(s):

Type 1 Diabetes ◽

Blood Glucose ◽

Blood Glucose Level ◽

Rat Model ◽

Renal Injury ◽

Receptor Agonist ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Inflammatory Action

Download Full-text

Distinct regulations by septide and the neurokinin-1 tachykinin receptor agonist [pro9]substance P of the N-methyl- d-aspartate-evoked release of dopamine in striosome- and matrix-enriched areas of the rat striatum

Neuroscience ◽

10.1016/0306-4522(96)00099-1 ◽

1996 ◽

Vol 73 (4) ◽

pp. 929-939 ◽

Author(s):

C. Gauchy ◽

M. Desban ◽

J. Glowinski ◽

M.L. Kemel

Keyword(s):

Substance P ◽

Receptor Agonist ◽

Rat Striatum ◽

Tachykinin Receptor ◽

Download Full-text

GLP-1 Receptor Agonist as Adjuvant Therapy in Type 1 Diabetes: No Apparent Benefit for Beta-Cell Function or Glycemia

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/clinem/dgaa314 ◽

2020 ◽

Vol 105 (8) ◽

pp. e3000-e3002

Author(s):

Maria J Redondo ◽

Fida Bacha

Keyword(s):

Type 1 Diabetes ◽

Adjuvant Therapy ◽

Beta Cell ◽

Beta Cell Function ◽

Receptor Agonist ◽

Download Full-text

Progranulin promotes diabetic fracture healing in mice with type 1 diabetes

Annals of the New York Academy of Sciences ◽

10.1111/nyas.14208 ◽

2019 ◽

Vol 1460 (1) ◽

pp. 43-56 ◽

Author(s):

Jianlu Wei ◽

Lei Zhang ◽

Yuanjing Ding ◽

Ronghan Liu ◽

Yuqi Guo ◽

...

Keyword(s):

Type 1 Diabetes ◽

Fracture Healing

Download Full-text

Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes

Diabetologia ◽

10.1007/s00125-010-2028-x ◽

2011 ◽

Vol 54 (4) ◽

pp. 965-978 ◽

Author(s):

R. Kodera ◽

K. Shikata ◽

H. U. Kataoka ◽

T. Takatsuka ◽

S. Miyamoto ◽

...

Keyword(s):

Type 1 Diabetes ◽

Blood Glucose ◽

Blood Glucose Level ◽

Rat Model ◽

Renal Injury ◽

Receptor Agonist ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Inflammatory Action

Download Full-text

Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/dom.12883 ◽

2017 ◽

Vol 19 (5) ◽

pp. 613-614 ◽

Author(s):

Manfredi Rizzo ◽

Ali A. Rizvi ◽

Giorgio Sesti

Keyword(s):

Type 1 Diabetes ◽

Receptor Agonist ◽

Cardiovascular Effects ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Addition of glucagon‐like peptide‐1 receptor agonist therapy to insulin in C‐peptide‐positive patients with type 1 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/dom.13609 ◽

2019 ◽

Vol 21 (4) ◽

pp. 1054-1057

Author(s):

Nitesh D. Kuhadiya ◽

Ben Prohaska ◽

Husam Ghanim ◽

Paresh Dandona

Keyword(s):

Type 1 Diabetes ◽

Receptor Agonist ◽

Agonist Therapy ◽

C Peptide ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Role of Additional GLP-1 Receptor Agonist to Insulin Regimen in Type 1 Diabetes among Pediatric Age

International Journal Of Pharmaceutical Research And Allied Sciences ◽

10.51847/fu8wdco3du ◽

2021 ◽

Vol 10 (3) ◽

pp. 141-146

Author(s):

Hussain Abdrabalrasool Alturaifi ◽

Nof Tarq Alzayyat ◽

Majed Shuraya Mohammed Alshahrani ◽

Mujtaba Matar M Alnakhli ◽

Abdulrahman Almuataz W Ezzi ◽

...

Keyword(s):

Type 1 Diabetes ◽

Receptor Agonist ◽

Insulin Regimen ◽

Download Full-text

Faculty Opinions recommendation of Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8727957.9242055 ◽

2011 ◽

Author(s):

Carolyn Ecelbarger

Keyword(s):

Type 1 Diabetes ◽

Blood Glucose ◽

Blood Glucose Level ◽

Rat Model ◽

Renal Injury ◽

Receptor Agonist ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Inflammatory Action

Download Full-text